Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001553350-24-000151
Filing Date
2024-10-01
Accepted
2024-10-01 16:01:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G l1cap_13g.htm SC 13G 40997
  Complete submission text file 0001553350-24-000151.txt   42789
Mailing Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

EIN.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Subject) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94408 | Film No.: 241343121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)